TrialCancer reports (Hoboken, N.J.)2021

Effectiveness and safety profile of pembrolizumab for metastatic urothelial cancer: A retrospective single-center analysis in Japan.

Motohiro Fujiwara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.